The activity of CAT was increased in all but one (PHG) of the experimental groups (PHG: +35.1%; NAFLD: +171.7% p < 0.01; NAFLD+PHG: +364% p < 0.0001; NAFLD+NAC: +244.7% p < 0.0001; NAFLD+ALA: +246.4% p < 0.0001) when compared to the control and significantly higher in NAFLD+PHG when compared to other groups. Here, CAT is linked to metabolic dysfunction-associated steatotic liver disease.